Content
Frontiers of Medicine >> 2022, Volume 16, Issue 5 doi: 10.1007/s11684-022-0951-0
Targeting apoptosis to manage acquired resistance to third generation EGFR inhibitors
Abstract
Keywords
acquired resistance ; EGFR inhibitor ; apoptosis ; lung cancer
Content